Spots Global Cancer Trial Database for haic+serplulimab（hlx10）+ bevacizumab biosimilar（hlx04）
Every month we try and update this database with for haic+serplulimab（hlx10）+ bevacizumab biosimilar（hlx04） cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients | NCT06370065 | Advanced Hepato... | HAIC+Serplulima... | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
